How to Buy Vertex Pharmaceuticals Stock
Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF).
Vertex Pharmaceuticals stock last closed at $526.19, up 0.73% from the previous day, and has increased 37.79% in one year. It has overperformed other stocks in the Biotechnology industry by 0.59 percentage points. Vertex Pharmaceuticals stock is currently +36.89% from its 52-week low of $384.39, and -6.08% from its 52-week high of $560.25.
There are currently 253.46M VRTX shares outstanding. The market capitalization of VRTX is $133.37B. In the last 24 hours, 745,000 VRTX shares were traded.
How to Buy Vertex Pharmaceuticals Stock
Wondering how to invest in Vertex Pharmaceuticals stock? Here's how.
- Decide where to buy Vertex Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Vertex Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Select your method of payment and add your info.
- Research Vertex Pharmaceuticals stock: The Vertex Pharmaceuticals ticker symbol is VRTX. Is Vertex Pharmaceuticals stock a good investment? Should you buy shares of VRTX? How do VRTX's underlying business fundamentals look? Do top analysts think Vertex Pharmaceuticals is a good buy? Why has VRTX's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if VRTX is a good stock to buy).
- Execute your VRTX purchase: Decide if you will purchase VRTX shares at the current market price or use a limit order to buy VRTX stock at a given price.
- Get the latest scoop on your investment in VRTX: Create a watchlist to important updates regarding your position in Vertex Pharmaceuticals stock.
Step 1: Decide where to buy Vertex Pharmaceuticals stock
You will need an online brokerage account to access the NASDAQ market and buy VRTX shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal info so you are able to invest in VRTX stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open a new trading account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've finished signing up on the best stock market app for beginners, you need to deposit funds:
Watch the walkthrough below for more details transferring funds into your new brokerage account.
Step 4: Research Vertex Pharmaceuticals stock
After you have selected the best place to buy Vertex Pharmaceuticals stock, it's important to research their stock before you buy, so you can comprehend the risk and opportunity.
Vertex Pharmaceuticals Metrics
Fundamentals of VRTX
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on VRTX's stock page.
Is VRTX stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge VRTX's intrinsic value.
Using relative valuations ratios:
- VRTX may be overvalued based on its P/E ratio of 30.36x, relative to Biotechnology industry P/E ratio of 14.87x
- VRTX may be overvalued based on its P/B ratio of 6.59x, relative to Biotechnology industry P/B ratio of 5.19x
- VRTX may be overvalued based on its PEG ratio of 2.28x
You can access more valuation research on VRTX's stock here.
VRTX Financial Overview
Pros:
- VRTX earnings of $5.28B is not sufficient to cover its interest payments.
- VRTX profit margin has gone up from 31.9% to 35% in the past year.
- VRTX's operating cash flow of $4.29B allows it to safely service it's debt of $1.98B.
- VRTX has a low debt to equity ratio of 0.35.
- There are more short-term assets than short-term liabilities on the VRTX balance sheet.
- There are more short-term assets than long-term liabilities on the VRTX balance sheet.
Cons:
- Total VRTX debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy VRTX stock
Out of 11 sell side analysts who give ratings on VRTX, the consensus analyst rating on VRTX is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent VRTX Analyst Forecasts
Carter Gould, a top 10% analyst from Cantor Fitzgerald maintains VRTX with a strong buy rating and raises their VRTX price target from $590.00 to $595.00, on Aug 4, 2026.
Cantor Fitzgerald's Carter Gould raised their price target on Vertex Pharmaceuticals (NASDAQ: VRTX) by 0.8% from $590 to $595 on 2026/08/04. The analyst maintained their Strong Buy rating on the stock.
Vertex Pharmaceuticals reported its Q2 2026 earnings.
Raising their price target, Gould said broad commercial momentum across Alyftrek, Casgevy, and Journavx delivered "strong" quarterly results.
Looking toward 2027, catalysts for Vertex Pharmaceuticals include pove and Palsonify that could further diversify the portfolio, the analyst added.
Earnings Report
For Q2 2026, Vertex Pharmaceuticals reported:
- EPS of $4.73, which missed the Zacks Consensus Estimate of $4.79 but beat Q2 2025's $4.52.
- Revenue of $3.33B, which beat the Zacks Consensus Estimate by 3.32% and Q2 2025's $2.96B.
For FY 2026, management guided:
- Revenue of $13.1B to $13.2B, up from the prior $12.95B to $13.1B.
President & CEO Reshma Kewalramani, M.D., commented: “Vertex delivered excellent second quarter results, expanding our leadership in cystic fibrosis; delivering strong revenue growth in sickle cell disease, beta thalassemia, and acute pain; and with the pending acquisition of Crinetics, adding rare endocrine diseases as our fifth pillar, further diversifying our portfolio.
“With this breadth of commercial and clinical opportunities, we look forward to bringing more medicines to more patients around the globe and in so doing, creating long-term value.”
Whitney Ijem, a top 7% analyst from Canaccord Genuity maintains VRTX with a hold rating and raises their VRTX price target from $436.00 to $442.00, on Aug 4, 2026.
Michael Yee, a top 12% analyst from UBS maintains VRTX with a strong buy rating and raises their VRTX price target from $545.00 to $585.00, on Jul 13, 2026.
Brian Abrahams, a top 14% analyst from RBC Capital maintains VRTX with a buy rating and raises their VRTX price target from $543.00 to $570.00, on Jul 7, 2026.
Brian Skorney, a top 18% analyst from Baird maintains VRTX with a sell rating and raises their VRTX price target from $330.00 to $350.00, on Jul 7, 2026.
You can dig deeper into what analysts are projecting on the Vertex Pharmaceuticals stock forecast page.
Metrics for Advanced VRTX Traders
Is VRTX Growing Revenue?
Last year, VRTX earnings were $4.41B. In the last five year, VRTX's earnings have gone up by 17.68% per year. This was faster than the Biotechnology industry average of 9.76%.
Last year, VRTX revenue was $12.59B. Over the past five year, VRTX's revenue has grown by 13.5% per year. This was slower than the Biotechnology industry average of 31.98%.
Dive into VRTX's earnings and revenue performance here.
Latest Insiders Trades at VRTX
In the last 12 months, executives and large shareholders at VRTX have sold more shares than they have bought.
Ourania Tatsis, EVP Chief Reg. Quality Off. of VRTX, was the latest VRTX insider to sell. They sold $787,485.00 worth of VRTX shares on Jul 2, 2026.
Learn more about who owns VRTX stock here.
Can I rely on VRTX as an income stream?
No, Vertex Pharmaceuticals doesn't provide an income stream by paying out dividends.
VRTX Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your VRTX purchase
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you want additional help with investing in stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your investment in VRTX
Now that you own some shares in VRTX, you'll want to stay up-to-date on your investment.
Create a watchlist to monitor your VRTX stock.
VRTX Feed
How to Buy Stock in Vertex Pharmaceuticals
To summarize, here are the 6 steps for buying Vertex Pharmaceuticals stock:
- Decide where to buy Vertex Pharmaceuticals stock
- Create your brokerage account
- Put funds into your brokerage account
- Research Vertex Pharmaceuticals stock
- Execute your VRTX purchase
- Get the latest scoop on your investment in VRTX
If you need a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep track of your investment in Vertex Pharmaceuticals, click below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.